CRESCENT BIOPHARMA, INC.

Regulatory Filings • Apr 20, 2022

CORRESP 1 filename1.htm

April 20, 2022

VIA EDGAR

Alan Campbell

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Re:
Registration Statement on Form S-3; File No. 333-263297

Acceleration Request

Requested Date: Friday, April 22, 2022
Requested Time: 4:00 p.m. Eastern Time

Dear Mr. Campbell:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-263297) (the “ Registration Statement ”) to become effective on Friday, April 22, 2022, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “ Staff ”).

Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant, at (703) 456-8043, or in her absence, Brian Leaf at (703) 456-8053.

Very truly yours,
GLYCOMIMETICS, INC.

By:
Brian M. Hahn
Chief Financial Officer

Field: Page; Sequence: 1; Options: Last

Field: /Page